This study is in progress, not accepting new patients
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
Summary
- Eligibility
- for females ages 18-130 (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Gottfried Konecny
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- AstraZeneca
- Links
- Redacted Clinical Study Protocol Redacted Statistical Analysis Plan Redacted Statistical Analysis Plan #2
- ID
- NCT01844986
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 450 people participating
- Last Updated